A 9-year-old with known Systemic Juvenile Idiopathic Arthritis develops Macrophage Activation Syndrome (MAS) that is refractory to high-dose corticosteroids. You decide to add a second agent that acts predominantly on T cells and is highly effective in the treatment of MAS. Which medication best fits this description?